WallStreetZenWallStreetZen

NASDAQ: XOMA
Xoma Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for XOMA

Based on 1 analyst offering 12 month price targets for Xoma Corp

Min Forecast
$123.00+279.28%
Avg Forecast
$123.00+279.28%
Max Forecast
$123.00+279.28%

Should I buy or sell XOMA stock?

Based on 1 analyst offering ratings for Xoma Corp.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although XOMA's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates XOMA as a "Hold". Stocks with a Zen Rating of Hold have beat the market by +7.53%. Learn More

Be the first to know when Wall Street analysts revise their XOMA stock forecasts and price targets.

XOMA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-12-02

1 of 1

Forecast return on equity

Is XOMA forecast to generate an efficient return?

Company
27.65%
Industry
137.48%
Market
70.82%
XOMA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is XOMA forecast to generate an efficient return on assets?

Company
10.5%
Industry
22.54%
XOMA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

XOMA earnings per share forecast

What is XOMA's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.79
Avg 2 year Forecast
-$0.47
Avg 3 year Forecast
$0.41

XOMA revenue forecast

What is XOMA's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$29.0M+33.99%
Avg 2 year Forecast
$36.2M+67.55%
Avg 3 year Forecast
$49.8M+130.26%
XOMA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XOMA revenue growth forecast

How is XOMA forecast to perform vs Biotechnology companies and vs the US market?

Company
31.11%
Industry
34.35%
Market
8.84%
XOMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XOMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XOMA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
XOMA$32.43$123.00+279.28%Buy
ENGN$8.65$27.75+220.81%Strong Buy
AMLX$5.55$9.00+62.16%Buy
CDXS$4.72$11.00+133.05%Strong Buy
VYGR$6.93$15.60+125.11%Buy
View Top Biotech Stocks

Xoma Stock Forecast FAQ

Is Xoma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: XOMA) stock is to Buy XOMA stock.

Out of 1 analyst, 0 (0%) are recommending XOMA as a Strong Buy, 1 (100%) are recommending XOMA as a Buy, 0 (0%) are recommending XOMA as a Hold, 0 (0%) are recommending XOMA as a Sell, and 0 (0%) are recommending XOMA as a Strong Sell.

If you're new to stock investing, here's how to buy Xoma stock.

What is XOMA's earnings growth forecast for 2024-2026?

(NASDAQ: XOMA) Xoma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.58%.

Xoma's earnings in 2024 is -$34,066,000.On average, 2 Wall Street analysts forecast XOMA's earnings for 2024 to be -$9,308,351, with the lowest XOMA earnings forecast at -$16,613,639, and the highest XOMA earnings forecast at -$2,003,063. On average, 3 Wall Street analysts forecast XOMA's earnings for 2025 to be -$5,498,997, with the lowest XOMA earnings forecast at -$11,429,241, and the highest XOMA earnings forecast at $2,003,063.

In 2026, XOMA is forecast to generate $4,830,916 in earnings, with the lowest earnings forecast at $2,120,890 and the highest earnings forecast at $7,540,943.

What is XOMA's revenue growth forecast for 2024-2026?

(NASDAQ: XOMA) Xoma's forecast annual revenue growth rate of 31.11% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.35%, and while it is forecast to beat the US market's average forecast revenue growth rate of 8.84%.

Xoma's revenue in 2024 is $21,606,000.On average, 2 Wall Street analysts forecast XOMA's revenue for 2024 to be $341,109,831, with the lowest XOMA revenue forecast at $319,311,793, and the highest XOMA revenue forecast at $362,907,868. On average, 2 Wall Street analysts forecast XOMA's revenue for 2025 to be $426,534,573, with the lowest XOMA revenue forecast at $422,999,756, and the highest XOMA revenue forecast at $430,069,390.

In 2026, XOMA is forecast to generate $586,190,469 in revenue, with the lowest revenue forecast at $583,244,789 and the highest revenue forecast at $589,136,150.

What is XOMA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: XOMA) forecast ROA is 10.5%, which is lower than the forecast US Biotechnology industry average of 22.54%.

What is XOMA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year XOMA price target, the average XOMA price target is $123.00, with the highest XOMA stock price forecast at $123.00 and the lowest XOMA stock price forecast at $123.00.

The Wall Street analyst predicted that Xoma's share price could reach $123.00 by Dec 2, 2025. The average Xoma stock price prediction forecasts a potential upside of 279.28% from the current XOMA share price of $32.43.

What is XOMA's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: XOMA) Xoma's current Earnings Per Share (EPS) is -$3.44. On average, analysts forecast that XOMA's EPS will be -$0.79 for 2024, with the lowest EPS forecast at -$1.41, and the highest EPS forecast at -$0.17. On average, analysts forecast that XOMA's EPS will be -$0.47 for 2025, with the lowest EPS forecast at -$0.97, and the highest EPS forecast at $0.17. In 2026, XOMA's EPS is forecast to hit $0.41 (min: $0.18, max: $0.64).

What is XOMA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: XOMA) forecast ROE is 27.65%, which is considered strong.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.